Surveillance of hepatocellular carcinoma (HCC) patients using Protein Induced by Vitamin K (PIVKA-II): A cost-utility analysis for Hong Kong
Man-Fung Yuen, David Wastlund, Tammie Tan Yan Lin, Qishi Zheng, Junqiao Chen, Kwan-Lung Ko · 2026
Read Surveillance of hepatocellular carcinoma (HCC) patients using Protein Induced by Vitamin K (PIVKA-II): A cost-utility analysis for Hong Kong by Man-Fung Yuen, David Wastlund, Tammie Tan Yan Lin, Qishi Zheng, Junqiao Chen, Kwan-Lung Ko (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0353882.txt.
Description
Man-Fung Yuen and five colleagues model a cheaper way to watch for liver cancer in Hong Kong, in this 2026 PLOS ONE health-economics study. People with chronic hepatitis B or cirrhosis need regular checks, usually ultrasound plus a blood marker, but ultrasound slots are scarce. The alternative pairs that same marker with a second blood protein that rises when vitamin K is absent — a combination needing no scan appointment.
In their simulation the blood-only strategy caught more cancers at an early, treatable stage and produced fewer false alarms. It also gained a sliver of healthy life per person while saving money. The benefit was clearest for hepatitis B patients without cirrhosis, who often wait longest for scans.
Catalog record
| CREATOR | Man-Fung Yuen, David Wastlund, Tammie Tan Yan Lin, Qishi Zheng, Junqiao Chen, Kwan-Lung Ko |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35077 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |